Cocrystal Pharma, Inc. (COCP) — Dilution Risk Analysis

Current Snapshot

Cocrystal Pharma, Inc. (COCP) has a DilutionWatch score of 71/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
19,263,200 Source
Public Float
9,124,950 Source
Float as % of Outstanding
47.4%

Dilution Risk Score

Score: 71/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 3 1, SC 13D/A 1, 4 4, 8-K 2, EFFECT 1, S-3 1.

FormFiledAccession
3 2026-08-21 0001493152-26-039674
SC 13D/A 2026-08-07 0001493152-26-036650
4 2026-08-06 0001493152-26-036396
4 2026-08-05 0001493152-26-036169
8-K 2026-08-03 0001493152-26-035743
EFFECT 2026-05-01 9999999995-26-001445
S-3 2026-04-23 0001493152-26-018732
4 2026-02-25 0001493152-26-008039
4 2026-02-09 0001493152-26-005773
8-K 2026-01-15 0001493152-26-002422

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $150,000,000 Source
Cash runway 7 months Source
Three-year share count growth 89.34% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 71/10) Source
Cash Runway
7 months Source
Shelf Registration Capacity
$150,000,000 Source
Share Count Growth (3-Year)
89.34% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.